Improving the analysis of monoclonal antibodies to ensure their safety and effectiveness
Sodium Dodecyl Sulfate Removal Interface to Enable Characterization of Fragment Impurities in Monoclonal Antibodies by Capillary Electrophoresis Sodium Dodecyl Sulfate Coupled to Mass Spectrometry
This study is working on improving the way we check monoclonal antibodies, which are important medicines for treating various health issues, to make sure they are safe and effective by finding and fixing any impurities that might show up during their production.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gmj Technologies, INC. NIH-funded |
| Lab location | 1 site (Everett, United States) |
| Project ID | NIH-10759354 on NIH RePORTER |
What this research studies
This research focuses on enhancing the methods used to analyze monoclonal antibodies (mAbs), which are important therapeutic proteins. The project aims to develop a new interface that allows for better detection and characterization of impurities in these antibodies, which can occur during their production and storage. By using advanced techniques like capillary electrophoresis coupled with mass spectrometry, the research seeks to improve the quality control processes for mAbs, ensuring they are safe and effective for patients. This could lead to more reliable treatments for various conditions that require monoclonal antibody therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who are receiving or may benefit from monoclonal antibody therapies for various medical conditions.
Not a fit: Patients who are not receiving monoclonal antibody treatments or those with conditions not treated by these therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective monoclonal antibody treatments for patients.
How similar studies have performed: Other research has shown success in improving analytical methods for biologics, indicating that this approach has potential for meaningful advancements.
Where this research is happening
Everett, United States
- Gmj Technologies, INC. — Everett, United States (Active)
Researchers
- Principal investigator: Dada, Oluwatosin — Gmj Technologies, INC.
- Study coordinator: Dada, Oluwatosin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.